3.5. MCP-4 and Eotaxin-3 May Exert Their Functions in COPD by Targeting Chemokine Receptor 2 (CCR2), 3 (CCR3), and 5 (CCR5). This evidence concerns the gene CCL26 and chronic obstructive pulmonary disease.